SAN FRANCISCO, June 7 /PRNewswire/ -- Nanodisc, Inc., a nano-bio
convergence company commercializing nanotechnologies for drug discovery and
delivery, announced that today at the BIO 2004 Annual International
Convention, Stephen Sligar, Ph.D., Nanodisc co-founder/chief scientific
officer and professor at the University of Illinois, will chair a panel
discussion focused on recent advancements that are enabling more effective
drug discovery efforts against membrane-bound protein targets. Dr. Sligar
will be joined by speakers including James Wells of Sunesis Pharmaceuticals;
Brian Hubbard of the Novartis Institutes for BioMedical Research; and Barry
Springer of 3-Dimensional Pharmaceuticals.
Compounds addressing membrane-bound targets constitute the majority of
pharmaceutical products marketed today. However, these targets are
notoriously difficult and expensive to study using traditional tools of drug
discovery because they lose their natural characteristics when removed from
their native environments, but cannot be easily manipulated and studied in
those environments. To address this challenge, Dr. Sligar developed
Nanodisc(TM) technology, a nano-scale, self-assembling disc that incorporates
target molecules such as membrane proteins in such a way that their natural
structural and functional characteristics are preserved and can be directly
investigated. Nanodisc technology is an important, less expensive enabler for
many molecular discovery approaches practiced by large life sciences
companies, and represents an important advance in drug formulation and
Dr. Sligar's panel, entitled "Membrane Proteins as Targets," will take
place Monday, June 7, at 11:00 AM (pacific time) in room 2018 West at the
Moscone Center in San Francisco. The BIO 2004 Annual International Convention
is being held June 6-9.
Nanodisc Inc. commercializes Nanodisc(TM) technology to enable more
effective and less expensive discovery of new drugs against membrane protein
targets, the largest class of drug targets, and for drug delivery and drug
formulation. Founded by Stephen Sligar, Ph.D., professor at the University of
Illinois, Nanodisc has a worldwide, exclusive commercial license for all
applications of Nanodisc technology with the U of I. For more information,
please visit www.nanodiscinc.com .
For further information please contact: Carin Canale of
Atkins + Associates, +1-858-336-3027, for Nanodisc, Inc.
SOURCE Nanodisc, Inc.